Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics

The aims of this clinical review are to: (i) highlight the importance of elevated baseline triglycerides (TG) in the setting of well-controlled low-density lipoprotein cholesterol (LDL-C) on statins as a major contributor to residual atherosclerotic cardiovascular disease (ASCVD) risk, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales: Boden, William E, Bhatt, Deepak L, Toth, Peter P, Ray, Kausik K, Chapman, M John, Lüscher, Thomas F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308541/
https://www.ncbi.nlm.nih.gov/pubmed/31872245
http://dx.doi.org/10.1093/eurheartj/ehz778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308541/
https://www.ncbi.nlm.nih.gov/pubmed/31872245
http://dx.doi.org/10.1093/eurheartj/ehz778

Ejemplares similares